Mr. Speaker, how can the minister guarantee that her director, who is on leave without pay and is lobbying on behalf of a number of drug companies, will not influence the recommendations of the bureau of veterinary drugs of Health Canada regarding somatotropin, since the director did not reveal his connection with the department?
In the House of Commons on December 6th, 1994. See this statement in context.